A lab disaster can come in the form of a fire, tornado, loss of electricity, cyber attack, compromised assay components, or more. With profitability and results on the line, many pharma labs are taking steps to develop disaster prevention strategies as well as carefully thought-out response plans.
We all like to enjoy our food. Herbs and spices add flavor and aromas to foods in order to entice the senses and build anticipation of an upcoming meal, while products like Manuka honey and extra virgin olive oil provide flavors that are different to conventional commodities.
When most of us encounter bacteria, we reach for a sanitizer. Researchers at the Cork Cancer Research Centre in Cork, Ireland, have a much different reaction. They view these single-cell microorganisms as literal torchbearers in advancing new therapies for infectious diseases especially as it relates to cancer.
Hybrid approaches to lab management are now becoming the norm, globally, with the lure and benefit of promising a more efficient, optimal operation within labs – including reducing undue burden on lab managers.
We all know the huge issue plastic is causing in our oceans today, but as it turns out this floating waste poses yet another danger: toxic heavy metals.
Over the last 20 years, Cisbio has become a leading Life Sciences company which develops, manufactures, and markets high quality kits and reagents for the drug discovery and life science markets used by pharmaceutical, biotechnology, academia and contract research organizations across the globe.
PerkinElmer's role in the historic Cassini spacecraft mission to Saturn.
New research by PerkinElmer confirms that PD-L1 protein expression levels in human breast cancer cells can be quickly and accurately assessed directly with the AlphaLISA human PD-L1 assay.
The Australian Institute of Marine Science (AIMS) is helping to sustain and restore damage to ecosystems due to a changing climate and microplastics contamination in the Great Barrier Reef.
North York General Hospital researchers have developed an Enhanced First Trimester Screen that is faster, less costly, but just as accurate as the standard Integrated Prenatal Screening protocol in detecting the risk for Down syndrome and Trisomy 18. The new test was developed with the help of PerkinElmer and is now in use in Ontario, Canada.